Literature DB >> 17620622

Drug-free holidays: pre-travel versus during travel malaria chemoprophylaxis.

G Dennis Shanks, Alan J Magill, David O Freedman, Jay S Keystone, David J Bradley, Robert Steffen.   

Abstract

Although efficacious forms of malaria chemoprophylaxis currently exist, many travelers to malaria-endemic areas fail to use them effectively. We suggest that taking antimalarial medications prior to travel may prevent more malaria by improving compliance. Treatment regimens of antimalarial drugs taken prior to travel could protect persons for up to one month of exposure. We urge additional testing of pre-travel malaria chemoprophylaxis regimens.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17620622

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  4 in total

1.  Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols.

Authors:  Erin Milner; William McCalmont; Jayendra Bhonsle; Diana Caridha; Jose Cobar; Sean Gardner; Lucia Gerena; Duane Goodine; Charlotte Lanteri; Victor Melendez; Norma Roncal; Jason Sousa; Peter Wipf; Geoffrey Stuart Dow
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

2.  Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.

Authors:  Mark E Polhemus; Shon Remich; Bernhards Ogutu; John Waitumbi; Marc Lievens; W Ripley Ballou; D Gray Heppner
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

3.  Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice.

Authors:  Geoffrey S Dow; Erin Milner; Ian Bathurst; Jayendra Bhonsle; Diana Caridha; Sean Gardner; Lucia Gerena; Michael Kozar; Charlotte Lanteri; Anne Mannila; William McCalmont; Jay Moon; Kevin D Read; Suzanne Norval; Norma Roncal; David M Shackleford; Jason Sousa; Jessica Steuten; Karen L White; Qiang Zeng; Susan A Charman
Journal:  Malar J       Date:  2011-06-06       Impact factor: 2.979

4.  Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.

Authors:  Geoffrey S Dow; Alan J Magill; Colin Ohrt
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.